Akèy › Ateroskleroz › Maryland
Etid klinik pou Ateroskleroz nan Maryland
12 etid pou Ateroskleroz ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
Causes and Natural History of Dyslipidemias
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 2 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT00353782Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 1 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT01143454New Heart Imaging Techniques to Evaluate Possible Heart Disease
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT01399385Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Ascension Saint Agnes Heart Care, Baltimore
- Metropolitan Cardiovascular Consultants, Beltsville
- Flourish Research - Bowie, Bowie
- ak 3 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Ascension Saint Agnes Heart Care, Baltimore
- MD Medical Research, Oxon Hill
- Velocity Clinical Research - Rockville, Rockville
Ap rekriteFaz 3
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 7 a 100 · Tout sèks · Mizajou Sep 8, 2026 · NCT03581318A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Annapolis
- Research Site, Baltimore
- Research Site, Baltimore
- ak 9 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Flourish Research Bowie, Bowie
- Anderson Medical Research, Ft. Washington
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Aug 7, 2026 · NCT06813911Pelacarsen Roll-over Extension Program
- Sinai Ct for Throm Res and Drug Dev, Baltimore
- Ascension Saint Agnes Heart Care, Baltimore
- Johns Hopkins Univ School of Med, Baltimore
- ak 4 plis
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Jul 29, 2026 · NCT06875973PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
- Johns Hopkins Hospital, Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 9, 2026 · NCT05994014Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 10 a 90 · Tout sèks · Mizajou Mar 23, 2026 · NCT06676046Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Rehabilitation R&D Service, Baltimore, MD, Baltimore
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT02915198Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.